Mexico Epilepsy Drugs Market Analysis

Mexico Epilepsy Drugs Market Analysis


$ 3999

Mexico Epilepsy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of epilepsy, increasing incidences of brain cancer in the geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the market. Some of the prominent global players in the epilepsy drugs market include Pfizer Inc., UCB S.A., GlaxoSmithKline plc, Novartis AG, and Eisai Co., Ltd.

ID: IN10MXPH281 CATEGORY: Pharmaceuticals GEOGRAPHY: Middle East AUTHOR: Riddhi Solanki

Buy Now

Mexico Epilepsy Drugs Market Analysis Summary

Mexico Epilepsy Drugs Market is valued at around $94.4 Mn in 2022 and is projected to reach $130.2 Mn by 2030, exhibiting a CAGR of 4.1% during the forecast period 2023-2030.

Epilepsy medications are used to treat a neurological disorder called epilepsy, which is characterized by recurring, unprovoked seizures. Globally, an estimated 5 million people are diagnosed with epilepsy each year, The prevalence of epilepsy worldwide is 1%. The rising prevalence of epilepsy, increasing incidences of brain cancer in the geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the market. Some of the prominent global players in the epilepsy drugs market include Pfizer Inc., UCB S.A., GlaxoSmithKline plc, Novartis AG, and Eisai Co., Ltd.

Market Dynamics

Market Growth Drivers

  1. Prevalence: Epilepsy is a common neurological illness that affects millions of individuals worldwide. The increasing prevalence of epilepsy is a primary driving force in the epileptic medications market. The market is expanding due to increased demand for effective and safe drugs to treat seizures and enhance patient outcomes
  2. Technological Advances in Drug Development: Novel antiepileptic medicines (AEDs) with higher efficacy and fewer side effects have been discovered as a result of advances in pharmaceutical research and development. Market growth is being driven by the development of innovative drug formulations, such as extended-release formulations and combination medicines
  3. Rising Research and Development Investments: Pharmaceutical companies and research institutions are investing heavily in the development of novel epilepsy medications. Funding availability and collaborations between academia and industry are propelling innovation and the development of novel therapeutic alternatives
  4. Increasing Diagnosis and Awareness: Increased epilepsy awareness, combined with advancements in diagnostic tools, has resulted in earlier and more accurate diagnoses of the disorder. This has resulted in a bigger patient population requiring pharmaceutical therapies, raising the demand for epilepsy medications

Market Restraints

  1. Side Effects and Safety Concerns: Epilepsy medications may have side effects and raise safety concerns. Adverse effects such as sleepiness, dizziness, cognitive impairment, and mood disturbances might have an impact on patient compliance and limit the usage of particular drugs. Long-term safety issues and probable drug combinations provide market obstacles
  2. Generic Competition: Several epilepsy medicines have lost or are close to losing patent protection, resulting in increased generic competition. Generic versions of antiepileptic medications are frequently less expensive, posing a threat to the market expansion of branded drugs
  3. Limited Treatment Options for Refractory Epilepsy: Some epileptic individuals do not respond satisfactorily to existing treatments, resulting in refractory or drug-resistant seizures. According to the International League Against Epilepsy, 30% of epileptic patients do not react to the medicine, therefore advanced, high-cost surgical procedures are necessary

Competitive Landscape

Key Players

  • Pfizer Inc.
  • UCB S.A.
  • GlaxoSmithKline plc
  • Novartis AG
  • Eisai Co., Ltd.

Development in the Epilepsy Drugs Market

Phase I study is under process by the University of Saskatchewan and will assess the safety and tolerability of a cannabidiol-enriched Cannabis Herbal Extract in a small group of children with refractory epileptic encephalopathy.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Mexico Epilepsy Drugs Market Segmentation

By Drug Class

  • First Generation AEDs
  • Phenytoin
  • Carbamazepine
  • Others
  • Second Generation AEDs
  • Lamotrigine
  • Levetiracetam
  • Third Generation AEDs
  • Eslicarbazepine acetate
  • Perampanel
  • Others

By Type of Seizures

  • Generalized Seizures
  • Tonic-clonic
  • Absence
  • Myoclonic
  • Focal (Partial) Seizures
  • Simple partial
  • Complex partial
  • Others

By Age Group

  • Pediatric Epilepsy Drugs
  • Adult Epilepsy Drugs

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Clinics

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 27 February 2024
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up